BioCryst Pharmaceuticals News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

08.02.16	MÄRKTE USA/Wall Street folgt Ölpreisen nach unten (Dow Jones)
10.08.15	XBIT Expands XCITE, COLL To Face FDA Panel, BCRX Plunges On Study Results Delay (RTTNews)
13.05.15	BioCryst Begins Phase 1 Trial Of BCX7353 For Treatment Of Hereditary Angioedema (RTTNews)
26.01.15	BioCryst Pharma Says FDA Grants Fast Track Designation For BCX4161 - Quick Facts (RTTNews)
14.01.15	BioCryst Shares Up After Positive Opinion On BCX4161 By EMA (RTTNews)
14.01.15	BioCryst Pharma Receives Positive Opinion From EU For Angiodema Compound BCX4161 (RTTNews)
05.01.15	BioCryst Pharma Appoints Lynne Powell As Chief Commercial Officer - Quick Facts (RTTNews)
24.12.14	BLRX Does A Deal, CRMD Enters Arabia, IG Exceeds Goal, See What's New In GRANIX (RTTNews)
22.12.14	BioCryst Pharma Says FDA Approves RAPIVAB In Acute Uncomplicated Influenza (RTTNews)
08.10.14	BioCryst Pharma To Present Rapivab Trial Results For Treatment Of Influenza (RTTNews)
01.10.14	MÄRKTE USA/Wall Street stürzt auf tiefsten Stand seit Mitte August (Dow Jones)
29.08.14	BioCryst Gets Additional Funding For Non-Human Primate Study Of BCX4430 In Ebola (RTTNews)
27.05.14	BioCryst: OPuS-1 Phase 2a Trial Of BCX4161 Meets Primary Efficacy Endpoint (RTTNews)
27.05.14	BCRX To Watch Out For, GTIV Adopts Poison Pill, TEVA, QGEN, DRTX Get FDA Nod (RTTNews)
26.02.14	ANIK Needs Your Attention, DARA Gets A Double Blessing, ITMN ASCENDs So High (RTTNews)
30.12.13	What Made These Stocks Winners In 2013? (RTTNews)
17.10.13	Technical Study: Amgen Inc., Questcor Pharmaceuticals Inc., PDL BioPharma Inc., and BioCryst Pharma Inc. (PR Newswire)
25.09.13	Data Presentations, FDA Approvals, Board Appointments, Updated Clinical Results and New Contracts - Research Report on Vertex, Celgene, NPS Pharmaceuticals, Cyclacel and BioCryst (PR Newswire)
20.09.13	Today's Research: Amgen Inc., BioCryst Pharmaceuticals Inc., PDL BioPharma Inc., and Questcor Pharmaceuticals Inc. (PR Newswire)
20.09.13	Did You Buy These Stocks? (RTTNews)
27.08.13	New Programs, Product Launches, Corporate Announcements and Financial Results - Research Report on Aetna, Illumina, Pharmacyclics, WellCare, and BioCryst (PR Newswire)
14.08.13	Morning Research: BioCryst Pharma Inc., Questcor Pharma Inc., PDL BioPharma Inc., and Amgen Inc. (PR Newswire)
12.08.13	Public Offerings of Common Stock, Financial Results, and Significant Progress in Key Development Programs - Research Report on BioCryst, Exelixis, Idenix, Puma Biotechnology, and Halozyme (PR Newswire)
05.08.13	Accretive Collaborations, Strengthened Management, and Earnings Release Schedules - Research Report on Seattle Genetics, Santarus, BioCryst, NPS, and PDL BioPharma (PR Newswire)
24.07.13	Marketing Applications, Product Launches, Commencement of Studies, Collaborations, and Release of Funding - Research Report on Biogen Idec, Illumina, Santarus, Celsion, and BioCryst (PR Newswire)
23.07.13	Tuesday's Biotech Watch List - Alliqua, BioCryst Pharmaceuticals, Trovagene, Delcath Systems, Array BioPharma (PR Newswire)
22.07.13	Pre-market Movers For July 22 (MCD, HAS, SPTN, NAFC, HAL, HIMX, BCRX, PETS, SIX) (RTTNews)
22.07.13	BioCryst Pharma To Begin Phase 2a Trial Of Oral Kallikrein Inhibitor BCX4161 (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

CieFinRichemont	137.35	1.40 %	K V
Sonova Hldg	297.30	1.29 %	K V
Logitech Intl	74.86	1.22 %	K V
Nestle	75.22	1.02 %	K V
Alcon	76.32	0.95 %	K V
UBS Group	28.17	-0.67 %	K V
Swiss Re	131.95	-0.68 %	K V
Geberit	533.80	-0.78 %	K V
Lonza Grp	541.40	-0.81 %	K V
Kuehne+Nagel Int	202.60	-1.65 %	K V

Nachrichten zu BioCryst Pharmaceuticals

Aktien Top/Flop

Meistgelesene Nachrichten